Top Markets
#1 GoPlus Security GoPlus Security +38.24%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.88%
#3 Wrapped NXM Wrapped NXM +14.47%
#4 Status Status +14.45%
#5 Pons Pons +14.35%
#6 Tutorial Tutorial +13.89%
#7 Verus Coin Verus Coin +12.97%
#8 SkyAI SkyAI +10.81%
#9 o1.exchange o1.exchange +10.65%
#10 BankrCoin BankrCoin +9.32%
Coin of the day
GoPlus Security GoPlus Security
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pure Biologics Spólka Akcyjna Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna

PUR
Classifica tra le azioni #33923
Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise,... Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic molecules. A significant offering is PureApta, a adaptable platform engineered for the in vitro selection of modified aptamers, suitable for both medical treatment and diagnostic applications. The firm is also actively pursuing the development of localized therapies aimed at assisting individuals afflicted by neurological autoimmune disorders, including conditions like neuromyelitis optica and myasthenia gravis. Founded in 2010, Pure Biologics Spólka Akcyjna is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$0.8248572
Ultima sincronizzazione: 2026-08-07
Capitalizzazione di mercato
$6.60M
Variazione (1 giorno)
35.02%
Variazione (1 anno)
-54.35%
Paese
PL
Scambia Pure Biologics Spólka Akcyjna (PUR)

Categoria

Healthcare
Rapporto P/B per Pure Biologics Spólka Akcyjna (PUR)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pure Biologics Spólka Akcyjna, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Pure Biologics Spólka Akcyjna da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE